Company News
- 2019-07-05
FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
- 2019-07-04
New synthetic technology for medicines and fine chemicals
A University of Tokyo research group has succeeded in synthesizing (R)- and (S)-rolipram, the active component of
Tel:
Skype:
QQ:
Wechat: